文献速递自身炎症与 IgG4 相关病血管炎其他结缔组织病

18F-FDG-PET/CT在不明原因发热和不明原因炎症病因诊断中的价值:前瞻性研究数据

The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.
PubMed 文献 · Ann Rheum Dis · 2017-09-19

该前瞻性研究纳入240例不明原因发热(FUO)或不明原因炎症(IUO)患者,在标准诊断流程基础上加做18F-FDG-PET/CT,评估其对最终诊断的帮助。190例(79.2%)建立诊断,136例(56.7%)PET/CT阳性且有助于诊断;年龄>50岁、CRP>30 mg/L及无发热与诊断性PET/CT相关。

要点

  • 18F-FDG-PET/CT在超过50%的FUO/IUO病例中有助于确定正确诊断。
  • 无间歇性发热、年龄>50岁和CRP>30 mg/L增加诊断性PET/CT的可能性。
  • FUO组最常见诊断为成人Still病(15.3%),IUO组为大血管炎(21.1%)和风湿性多肌痛(18.3%)。

核心结论

  • 18F-FDG-PET/CT在超过50%的FUO和IUO病例中有助于确定正确诊断。
  • 无间歇性发热、较高年龄和CRP水平升高增加诊断性18F-FDG-PET/CT的可能性。

研究设计与样本

  • 前瞻性研究,纳入240例FUO或IUO患者,其中FUO 72例、IUO 142例、既往FUO/IUO 26例。
  • 患者在标准诊断流程基础上接受18F-FDG-PET/CT扫描,结果分类为有助于或非有助于建立最终诊断。
  • 采用二元逻辑回归识别与诊断性18F-FDG-PET/CT相关的临床参数。

主要发现

  • 190例患者(79.2%)建立诊断。
  • FUO组最常见诊断为成人Still病(15.3%),IUO组为大血管炎(21.1%)和风湿性多肌痛(18.3%),既往FUO/IUO组为IgG4相关病(15.4%)。
  • 136例患者(全部患者的56.7%、有诊断患者的71.6%)18F-FDG-PET/CT阳性且有助于发现诊断。
  • 诊断性18F-FDG-PET/CT的预测标志包括年龄超过50岁(p=0.019)、C反应蛋白(CRP)水平超过30 mg/L(p=0.002)和无发热(p=0.001)。

关键数值与推荐

  • 年龄超过50岁与诊断性18F-FDG-PET/CT相关(p=0.019)。
  • CRP水平超过30 mg/L与诊断性18F-FDG-PET/CT相关(p=0.002)。
  • 无发热与诊断性18F-FDG-PET/CT相关(p=0.001)。

临床怎么用

  • 对FUO或IUO患者,在标准诊断流程基础上可考虑加做18F-FDG-PET/CT以辅助病因诊断。
  • 年龄超过50岁、CRP超过30 mg/L且无发热的FUO/IUO患者,18F-FDG-PET/CT更可能提供诊断帮助。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fever of unknown origin (FUO) and inflammation of unknown origin (IUO) are diagnostically challenging conditions. Diagnosis of underlying disease may be improved by 18F-fluorodesoxyglucose positron emission tomography (18F-FDG-PET). METHODS: Prospective study to test diagnostic utility of 18F-FDG-PET/CT in a large cohort of patients with FUO or IUO and to define parameters that increase the likelihood of diagnostic 18F-FDG-PET/CT. Patients with FUO or IUO received 18F-FDG-PET/CT scanning in addition to standard diagnostic work-up. 18F-FDG-PET/CT results were classified as helpful or non-helpful in establishing final diagnosis. Binary logistic regression was used to identify clinical parameters associated with a diagnostic 18F-FDG-PET/CT. RESULTS: 240 patients were enrolled, 72 with FUO, 142 with IUO and 26 had FUO or IUO previously (exFUO/IUO). Diagnosis was established in 190 patients (79.2%). The leading diagnoses were adult-onset Still's disease (15.3%) in the FUO group, large vessel vasculitis (21.1%) and polymyalgia rheumatica (18.3%) in the IUO group and IgG4-related disease (15.4%) in the exFUO/IUO group. In 136 patients (56.7% of all patients and 71.6% of patients with a diagnosis), 18F-FDG-PET/CT was positive and helpful in finding the diagnosis. Predictive markers for a diagnostic 18F-FDG-PET/CT were age over 50 years (p=0.019), C-reactive protein (CRP) level over 30 mg/L (p=0.002) and absence of fever (p=0.001). CONCLUSION: 18F-FDG-PET/CT scanning is helpful in ascertaining the correct diagnosis in more than 50% of the cases presenting with FUO and IUO. Absence of intermittent fever, higher age and elevated CRP level increase the likelihood for a diagnostic 18F-FDG-PET/CT.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Schönau V, Vogel K, Englbrecht M, et al. The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2017. PMID: 28928271. doi:10.1136/annrheumdis-2017-211687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。